Imagin Medical Inc. (IMEXF)

[jesse]

Final Product Design on Track





Vancouver, B.C. and Boston, MA, March 2, 2017 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that the Company and Optel, Inc., its product design partner, have achieved the first steps of their plan for the manufacture and commercialization of the i/Blue™ Imaging System. The Company is working against the key milestones outlined below.



Proof of Concept: Underway - Overall objective is to reduce the size of the current prototype by 70% and create it as a mobile product that can be moved easily between different operating rooms. The platform will include four primary modules: illumination, imaging, image processing, and the power supply. Each module is currently being prototyped to verify that performance meets and/or exceeds specifications. The Company expects the modular platform to be the basis of its future systems.



Design and Construction of Pilot Production Device: 3Q 2017 – The device enclosure will house the four basic modules and be compatible with either cart or rack mounting and a touchscreen display located on its exterior to serve as the graphical user interface.

Verification and Validation Testing: 4Q 2017 - All verification and testing will be conducted in accordance with the requirements of the FDA’s Good Manufacturing Practices (GMP), the European medical device standard ISO 13485 and generally in accordance with other international medical device compliance requirements.



“Optel’s experience and success in the optical medical device field, combined with the capabilities of our development team, gives me confidence that we will achieve our goals on schedule,” commented Jim Hutchens, Imagin’s President and CEO.

Please find attached the complete news release.



Thanks for all your support.



If you have any questions please feel free to email me or give me a call.



Link to our website:



http://imaginmedical.com/



All the best,



Bill





Bill Galine

imagin_logo_v2.png

775-737-3292

[e-mail]